Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-10-13

AUTHORS

H Takano, H Hasegawa, H Narumi, S Shindo, H Mizuma, Y Kuwabara, Y Kobayashi, I Komuro,

ABSTRACT

The Valsartan Amlodipine Randomized Trial (VART) was performed to compare the beneficial effects of valsartan and amlodipine on cardiovascular events in Japanese hypertensive patients. In this subanalysis of the VART, we assessed the relationship between home blood pressure (HBP) levels and cardiovascular events in the enrolled patients. We enrolled 1021 patients with mild-to-moderate hypertension in the VART. The participants were allocated randomly to either the valsartan group or the amlodipine group. The primary end point was a composite of all-cause death, sudden death, cerebrovascular events, cardiac events, vascular events and renal events. A total of 621 patients (valsartan group: 305 and amlodipine group: 316) completed the measurements of HBP (morning and evening) throughout the trial. Both the agents evenly and significantly lowered morning HBP and evening HBP throughout the trial. There was no significant difference in the primary end point between the two groups. However, we observed significant decreases in the left ventricular mass index and urinary albumin to creatinine ratio in the valsartan group but not in the amlodipine group. There were no significant differences in HBP levels and the main outcome of the cardiovascular events between the valsartan and amlodipine groups. However, in the valsartan group, significant improvements in left ventricular hypertrophy and microalbuminuria were observed. More... »

PAGES

656-663

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/jhh.2011.91

DOI

http://dx.doi.org/10.1038/jhh.2011.91

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031762448

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21993491


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuminuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amlodipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angina Pectoris", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asian Continental Ancestry Group", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cause of Death", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatinine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Death, Sudden", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertrophy, Left Ventricular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Valine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Valsartan", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takano", 
        "givenName": "H", 
        "id": "sg:person.0624235222.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624235222.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hasegawa", 
        "givenName": "H", 
        "id": "sg:person.01371272633.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371272633.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narumi", 
        "givenName": "H", 
        "id": "sg:person.01203207133.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203207133.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shindo", 
        "givenName": "S", 
        "id": "sg:person.01066760533.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066760533.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizuma", 
        "givenName": "H", 
        "id": "sg:person.01251322333.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251322333.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuwabara", 
        "givenName": "Y", 
        "id": "sg:person.0752532133.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752532133.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayashi", 
        "givenName": "Y", 
        "id": "sg:person.016657042642.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016657042642.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komuro", 
        "givenName": "I", 
        "id": "sg:person.01012024207.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012024207.33"
        ], 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/hr.2008.18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015339541", 
          "https://doi.org/10.1038/hr.2008.18"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250051259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035073261", 
          "https://doi.org/10.1007/s001250051259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-002-0946-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013509783", 
          "https://doi.org/10.1007/s00125-002-0946-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1291/hypres.31.1171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012898116", 
          "https://doi.org/10.1291/hypres.31.1171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2010.186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046315851", 
          "https://doi.org/10.1038/hr.2010.186"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-10-13", 
    "datePublishedReg": "2011-10-13", 
    "description": "The Valsartan Amlodipine Randomized Trial (VART) was performed to compare the beneficial effects of valsartan and amlodipine on cardiovascular events in Japanese hypertensive patients. In this subanalysis of the VART, we assessed the relationship between home blood pressure (HBP) levels and cardiovascular events in the enrolled patients. We enrolled 1021 patients with mild-to-moderate hypertension in the VART. The participants were allocated randomly to either the valsartan group or the amlodipine group. The primary end point was a composite of all-cause death, sudden death, cerebrovascular events, cardiac events, vascular events and renal events. A total of 621 patients (valsartan group: 305 and amlodipine group: 316) completed the measurements of HBP (morning and evening) throughout the trial. Both the agents evenly and significantly lowered morning HBP and evening HBP throughout the trial. There was no significant difference in the primary end point between the two groups. However, we observed significant decreases in the left ventricular mass index and urinary albumin to creatinine ratio in the valsartan group but not in the amlodipine group. There were no significant differences in HBP levels and the main outcome of the cardiovascular events between the valsartan and amlodipine groups. However, in the valsartan group, significant improvements in left ventricular hypertrophy and microalbuminuria were observed.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/jhh.2011.91", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1098658", 
        "issn": [
          "0950-9240", 
          "1476-5527"
        ], 
        "name": "Journal of Human Hypertension", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "primary end point", 
      "Japanese hypertensive patients", 
      "cardiovascular events", 
      "amlodipine group", 
      "valsartan group", 
      "hypertensive patients", 
      "home blood pressure levels", 
      "left ventricular mass index", 
      "end point", 
      "ventricular mass index", 
      "effect of valsartan", 
      "home blood pressure", 
      "blood pressure levels", 
      "significant differences", 
      "morning HBP", 
      "moderate hypertension", 
      "cause death", 
      "renal events", 
      "cerebrovascular events", 
      "cardiac events", 
      "vascular events", 
      "urinary albumin", 
      "HBP levels", 
      "randomized trials", 
      "creatinine ratio", 
      "ventricular hypertrophy", 
      "blood pressure", 
      "mass index", 
      "sudden death", 
      "MAIN OUTCOME", 
      "patients", 
      "beneficial effects", 
      "valsartan", 
      "significant decrease", 
      "trials", 
      "subanalysis", 
      "amlodipine", 
      "death", 
      "group", 
      "significant improvement", 
      "HBP", 
      "pressure levels", 
      "microalbuminuria", 
      "hypertension", 
      "hypertrophy", 
      "mild", 
      "events", 
      "outcomes", 
      "levels", 
      "differences", 
      "total", 
      "albumin", 
      "effect", 
      "participants", 
      "agents", 
      "index", 
      "decrease", 
      "improvement", 
      "pressure", 
      "relationship", 
      "ratio", 
      "point", 
      "measurements", 
      "composites", 
      "VART", 
      "Amlodipine Randomized Trial", 
      "measurements of HBP", 
      "evening HBP"
    ], 
    "name": "Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART", 
    "pagination": "656-663", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031762448"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/jhh.2011.91"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21993491"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/jhh.2011.91", 
      "https://app.dimensions.ai/details/publication/pub.1031762448"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_541.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/jhh.2011.91"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/jhh.2011.91'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/jhh.2011.91'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/jhh.2011.91'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/jhh.2011.91'


 

This table displays all metadata directly associated to this object as RDF triples.

304 TRIPLES      22 PREDICATES      124 URIs      111 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/jhh.2011.91 schema:about N03c2018a698c4137aa08bbe3ac98ae3b
2 N0957b48535614a4abd336fa33f25c2c6
3 N187d52a162154e808761c6bfc94e7bf8
4 N1bfc1bb11f5346a28d461b311884ea19
5 N292cb68334e4467f9b1c2db044dd05eb
6 N2c0887801b204467abdc586e4ca422f2
7 N45d98c7b00d24886b4706e63aad17311
8 N46e41eb9021c4be6a3d1c40f7bbeac62
9 N515d94cf0eed466d982ee231c433c989
10 N54fb15e359ac4c7190d26ee4bc24ca85
11 N5a45dd45849f432f836a57cd00657b13
12 N66b17c51dc274005ac11cbb4cf7704c2
13 N7242eae3888b48f3a4c77d9ac05ffda9
14 N79624bed01b74cdbb0a8421ec6019dca
15 N82047fe6ed944f92ae80d8102b462d15
16 N86f3ea7eca5b43588fb42e48aeff8445
17 N953c54fca55e43f59265b28023f423a4
18 Ncc95d4a0f456459987228dc5a19c6f9e
19 Nd97e7a14d2484cc2ad500fb8b6e6a1a8
20 Nda57c4eb4fdc4563ba95ace71a5cf6f7
21 Ndf812327a7cb45b594ba72538c1d8a71
22 Nebbb1620cb4d4df99f0d5c3d4b12ffc0
23 Nf072cb9d0b1844758dcdaa6d13b05c5d
24 Nf9376700a67f4cbeb317bd064cdb632e
25 Nfb2a7dd248f54ef0b648ae0ec58755a6
26 anzsrc-for:11
27 anzsrc-for:1102
28 schema:author N55ca1e1089f548a5b11cb88bb1887313
29 schema:citation sg:pub.10.1007/s00125-002-0946-y
30 sg:pub.10.1007/s001250051259
31 sg:pub.10.1038/hr.2008.18
32 sg:pub.10.1038/hr.2010.186
33 sg:pub.10.1291/hypres.31.1171
34 schema:datePublished 2011-10-13
35 schema:datePublishedReg 2011-10-13
36 schema:description The Valsartan Amlodipine Randomized Trial (VART) was performed to compare the beneficial effects of valsartan and amlodipine on cardiovascular events in Japanese hypertensive patients. In this subanalysis of the VART, we assessed the relationship between home blood pressure (HBP) levels and cardiovascular events in the enrolled patients. We enrolled 1021 patients with mild-to-moderate hypertension in the VART. The participants were allocated randomly to either the valsartan group or the amlodipine group. The primary end point was a composite of all-cause death, sudden death, cerebrovascular events, cardiac events, vascular events and renal events. A total of 621 patients (valsartan group: 305 and amlodipine group: 316) completed the measurements of HBP (morning and evening) throughout the trial. Both the agents evenly and significantly lowered morning HBP and evening HBP throughout the trial. There was no significant difference in the primary end point between the two groups. However, we observed significant decreases in the left ventricular mass index and urinary albumin to creatinine ratio in the valsartan group but not in the amlodipine group. There were no significant differences in HBP levels and the main outcome of the cardiovascular events between the valsartan and amlodipine groups. However, in the valsartan group, significant improvements in left ventricular hypertrophy and microalbuminuria were observed.
37 schema:genre article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N1d6a94a0f39a4a17acdd78fd8994bd65
41 Nfff5b602092b44e1bc84404e4477afdb
42 sg:journal.1098658
43 schema:keywords Amlodipine Randomized Trial
44 HBP
45 HBP levels
46 Japanese hypertensive patients
47 MAIN OUTCOME
48 VART
49 agents
50 albumin
51 amlodipine
52 amlodipine group
53 beneficial effects
54 blood pressure
55 blood pressure levels
56 cardiac events
57 cardiovascular events
58 cause death
59 cerebrovascular events
60 composites
61 creatinine ratio
62 death
63 decrease
64 differences
65 effect
66 effect of valsartan
67 end point
68 evening HBP
69 events
70 group
71 home blood pressure
72 home blood pressure levels
73 hypertension
74 hypertensive patients
75 hypertrophy
76 improvement
77 index
78 left ventricular mass index
79 levels
80 mass index
81 measurements
82 measurements of HBP
83 microalbuminuria
84 mild
85 moderate hypertension
86 morning HBP
87 outcomes
88 participants
89 patients
90 point
91 pressure
92 pressure levels
93 primary end point
94 randomized trials
95 ratio
96 relationship
97 renal events
98 significant decrease
99 significant differences
100 significant improvement
101 subanalysis
102 sudden death
103 total
104 trials
105 urinary albumin
106 valsartan
107 valsartan group
108 vascular events
109 ventricular hypertrophy
110 ventricular mass index
111 schema:name Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART
112 schema:pagination 656-663
113 schema:productId N879f073762d348b297ae534357f7c03b
114 N9fa6379372f24fa0a75ad0ff9194544b
115 Ndee88943f0464ae9b4dfffb1f1f990a3
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031762448
117 https://doi.org/10.1038/jhh.2011.91
118 schema:sdDatePublished 2022-01-01T18:24
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher N7252cafd5cd74a3da0709e12d3b3e061
121 schema:url https://doi.org/10.1038/jhh.2011.91
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N03c2018a698c4137aa08bbe3ac98ae3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Male
127 rdf:type schema:DefinedTerm
128 N0957b48535614a4abd336fa33f25c2c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Middle Aged
130 rdf:type schema:DefinedTerm
131 N13b7d47ddfe74a6197636c6d4c0e3e9a rdf:first N935d074925bb409f94b68906c1d57d62
132 rdf:rest rdf:nil
133 N187d52a162154e808761c6bfc94e7bf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Amlodipine
135 rdf:type schema:DefinedTerm
136 N1bfc1bb11f5346a28d461b311884ea19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 N1d6a94a0f39a4a17acdd78fd8994bd65 schema:volumeNumber 26
140 rdf:type schema:PublicationVolume
141 N292cb68334e4467f9b1c2db044dd05eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Angina Pectoris
143 rdf:type schema:DefinedTerm
144 N2c0887801b204467abdc586e4ca422f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Myocardial Infarction
146 rdf:type schema:DefinedTerm
147 N32c3b83df8c74a2d8ee1493bd5cdbfc6 rdf:first sg:person.01203207133.99
148 rdf:rest N590deabac25d46499e30af9c886623ae
149 N45d98c7b00d24886b4706e63aad17311 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Kidney Failure, Chronic
151 rdf:type schema:DefinedTerm
152 N46e41eb9021c4be6a3d1c40f7bbeac62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Antihypertensive Agents
154 rdf:type schema:DefinedTerm
155 N515d94cf0eed466d982ee231c433c989 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Hypertrophy, Left Ventricular
157 rdf:type schema:DefinedTerm
158 N54fb15e359ac4c7190d26ee4bc24ca85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Treatment Outcome
160 rdf:type schema:DefinedTerm
161 N55ca1e1089f548a5b11cb88bb1887313 rdf:first sg:person.0624235222.83
162 rdf:rest N7ec3cd6335b441c9bc84f423a44a8f0f
163 N590deabac25d46499e30af9c886623ae rdf:first sg:person.01066760533.40
164 rdf:rest Nc8934334be164a929b579f8048f2df8a
165 N5a45dd45849f432f836a57cd00657b13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged
167 rdf:type schema:DefinedTerm
168 N66b17c51dc274005ac11cbb4cf7704c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Cardiovascular Diseases
170 rdf:type schema:DefinedTerm
171 N7242eae3888b48f3a4c77d9ac05ffda9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Creatinine
173 rdf:type schema:DefinedTerm
174 N7252cafd5cd74a3da0709e12d3b3e061 schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 N79624bed01b74cdbb0a8421ec6019dca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Blood Pressure
178 rdf:type schema:DefinedTerm
179 N7ec3cd6335b441c9bc84f423a44a8f0f rdf:first sg:person.01371272633.17
180 rdf:rest N32c3b83df8c74a2d8ee1493bd5cdbfc6
181 N82047fe6ed944f92ae80d8102b462d15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Death, Sudden
183 rdf:type schema:DefinedTerm
184 N86f3ea7eca5b43588fb42e48aeff8445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Asian Continental Ancestry Group
186 rdf:type schema:DefinedTerm
187 N879f073762d348b297ae534357f7c03b schema:name dimensions_id
188 schema:value pub.1031762448
189 rdf:type schema:PropertyValue
190 N953c54fca55e43f59265b28023f423a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Valsartan
192 rdf:type schema:DefinedTerm
193 N9fa6379372f24fa0a75ad0ff9194544b schema:name doi
194 schema:value 10.1038/jhh.2011.91
195 rdf:type schema:PropertyValue
196 Na2c4172f46d34687ad66e74a531d3584 rdf:first sg:person.016657042642.17
197 rdf:rest Nd5f95e135b0b49f2913b99c6d065fa46
198 Nc8934334be164a929b579f8048f2df8a rdf:first sg:person.01251322333.16
199 rdf:rest Ncca4e78d05654cd583578a7b1f83eba0
200 Ncc95d4a0f456459987228dc5a19c6f9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Tetrazoles
202 rdf:type schema:DefinedTerm
203 Ncca4e78d05654cd583578a7b1f83eba0 rdf:first sg:person.0752532133.65
204 rdf:rest Na2c4172f46d34687ad66e74a531d3584
205 Nd5f95e135b0b49f2913b99c6d065fa46 rdf:first sg:person.01012024207.33
206 rdf:rest N13b7d47ddfe74a6197636c6d4c0e3e9a
207 Nd97e7a14d2484cc2ad500fb8b6e6a1a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Female
209 rdf:type schema:DefinedTerm
210 Nda57c4eb4fdc4563ba95ace71a5cf6f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Cause of Death
212 rdf:type schema:DefinedTerm
213 Ndee88943f0464ae9b4dfffb1f1f990a3 schema:name pubmed_id
214 schema:value 21993491
215 rdf:type schema:PropertyValue
216 Ndf812327a7cb45b594ba72538c1d8a71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Hypertension
218 rdf:type schema:DefinedTerm
219 Nebbb1620cb4d4df99f0d5c3d4b12ffc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Valine
221 rdf:type schema:DefinedTerm
222 Nf072cb9d0b1844758dcdaa6d13b05c5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Heart Failure
224 rdf:type schema:DefinedTerm
225 Nf9376700a67f4cbeb317bd064cdb632e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Albuminuria
227 rdf:type schema:DefinedTerm
228 Nfb2a7dd248f54ef0b648ae0ec58755a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Stroke
230 rdf:type schema:DefinedTerm
231 Nfff5b602092b44e1bc84404e4477afdb schema:issueNumber 11
232 rdf:type schema:PublicationIssue
233 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
234 schema:name Medical and Health Sciences
235 rdf:type schema:DefinedTerm
236 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
237 schema:name Cardiorespiratory Medicine and Haematology
238 rdf:type schema:DefinedTerm
239 sg:journal.1098658 schema:issn 0950-9240
240 1476-5527
241 schema:name Journal of Human Hypertension
242 schema:publisher Springer Nature
243 rdf:type schema:Periodical
244 sg:person.01012024207.33 schema:affiliation grid-institutes:grid.136593.b
245 schema:familyName Komuro
246 schema:givenName I
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012024207.33
248 rdf:type schema:Person
249 sg:person.01066760533.40 schema:affiliation grid-institutes:grid.136304.3
250 schema:familyName Shindo
251 schema:givenName S
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066760533.40
253 rdf:type schema:Person
254 sg:person.01203207133.99 schema:affiliation grid-institutes:grid.136304.3
255 schema:familyName Narumi
256 schema:givenName H
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203207133.99
258 rdf:type schema:Person
259 sg:person.01251322333.16 schema:affiliation grid-institutes:grid.136304.3
260 schema:familyName Mizuma
261 schema:givenName H
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251322333.16
263 rdf:type schema:Person
264 sg:person.01371272633.17 schema:affiliation grid-institutes:grid.136304.3
265 schema:familyName Hasegawa
266 schema:givenName H
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371272633.17
268 rdf:type schema:Person
269 sg:person.016657042642.17 schema:affiliation grid-institutes:grid.136304.3
270 schema:familyName Kobayashi
271 schema:givenName Y
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016657042642.17
273 rdf:type schema:Person
274 sg:person.0624235222.83 schema:affiliation grid-institutes:grid.136304.3
275 schema:familyName Takano
276 schema:givenName H
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624235222.83
278 rdf:type schema:Person
279 sg:person.0752532133.65 schema:affiliation grid-institutes:grid.136304.3
280 schema:familyName Kuwabara
281 schema:givenName Y
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752532133.65
283 rdf:type schema:Person
284 sg:pub.10.1007/s00125-002-0946-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1013509783
285 https://doi.org/10.1007/s00125-002-0946-y
286 rdf:type schema:CreativeWork
287 sg:pub.10.1007/s001250051259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035073261
288 https://doi.org/10.1007/s001250051259
289 rdf:type schema:CreativeWork
290 sg:pub.10.1038/hr.2008.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015339541
291 https://doi.org/10.1038/hr.2008.18
292 rdf:type schema:CreativeWork
293 sg:pub.10.1038/hr.2010.186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046315851
294 https://doi.org/10.1038/hr.2010.186
295 rdf:type schema:CreativeWork
296 sg:pub.10.1291/hypres.31.1171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012898116
297 https://doi.org/10.1291/hypres.31.1171
298 rdf:type schema:CreativeWork
299 grid-institutes:grid.136304.3 schema:alternateName Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
300 schema:name Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
301 rdf:type schema:Organization
302 grid-institutes:grid.136593.b schema:alternateName Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
303 schema:name Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
304 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...